Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells

被引:137
作者
Kadowaki, N
Antonenko, S
Ho, S
Rissoan, MC
Soumelis, V
Porcelli, SA
Lanier, LL
Liu, YJ
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA
[2] Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[4] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
关键词
cord blood; interleukin; 4; interferon gamma; autoimmune diseases; graft versus host disease;
D O I
10.1084/jem.193.10.1221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer T (NKT) cells are a highly conserved subset of T cells that have been shown to play a critical role in suppressing T helper cell type 1-mediated autoimmune diseases and graft versus host disease in an interleukin (IL)-4-dependent manner. Thus, it is important to understand how the development of IL-4- versus interferon (IFN)-gamma -producing NKT cells is regulated. Here, we show that NKT cells from adult blood and those from cord blood undergo massive expansion in cell numbers (500-70,000-fold) during a 4-wk culture with IL-2, IL-7, phytohemagglutinin, anti-CD3, and anti-CD28 mAbs. Unlike adult NKT cells that preferentially produce both IL-4 and IFN-gamma, neonatal NK7 cells preferentially produce IL-4 after polyclonal activation. Addition of type 2 dendritic cells (DC2) enhances the development of neonatal NKT cells into IL-4(+)IFN-gamma (-) NKT2 cells, whereas addition of type 1 dendritic cells (L)CZ) induces polarization towards IL-4(-)IFN-gamma (divided by) NKT1 cells. Adult NKT cells display limited plasticity for polarization induced by DC1 or DC2. Thus, newly generated NKT cells may possess the potent ability to develop into IL-4(divided by)IFN-gamma (-) NKT2 cells in response to appropriate stimuli and may thereafter acquire the tendency to produce both IL-1 and IFN-gamma.
引用
收藏
页码:1221 / 1226
页数:6
相关论文
共 25 条
[1]   Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells [J].
Arpinati, M ;
Green, CL ;
Heimfeld, S ;
Heuser, JE ;
Anasetti, C .
BLOOD, 2000, 95 (08) :2484-2490
[2]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[3]   A semiquantitative assay for CD8(+) T-cell-mediated suppression of human immunodeficiency virus type 1 infection [J].
Chen, Y ;
Rinaldo, C ;
Gupta, P .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (01) :4-10
[4]  
D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO
[5]  
2-I
[6]   Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes [J].
Dubois, B ;
Vanbervliet, B ;
Fayette, J ;
Massacrier, C ;
VanKooten, C ;
Briere, F ;
Banchereau, J ;
Caux, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :941-951
[7]   Requirements for CD1d recognition by human invariant V alpha 24(+) CD4(-)CD8(-) T cells [J].
Exley, M ;
Garcia, J ;
Balk, SP ;
Porcelli, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :109-120
[8]   Dendritic cells directly trigger NK cell functions:: Cross-talk relevant in innate anti-tumor immune responses in vivo [J].
Fernandez, NC ;
Lozier, A ;
Flament, C ;
Ricciardi-Castagnoli, P ;
Bellet, D ;
Suter, M ;
Perricaudet, M ;
Tursz, T ;
Maraskovsky, E ;
Zitvogel, L .
NATURE MEDICINE, 1999, 5 (04) :405-411
[9]   α/β-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10 [J].
Hammond, KJL ;
Poulton, LD ;
Palmisano, LJ ;
Silveira, PA ;
Godfrey, DI ;
Baxter, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (07) :1047-1056
[10]   Natural interferon α/β-producing cells link innate and adaptive immunity [J].
Kadowaki, N ;
Antonenko, S ;
Lau, JYN ;
Liu, YJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :219-225